Risk Factors for Open-angle Glaucoma in a Japanese Population: the Tajimi Study
Overview
Authors
Affiliations
Purpose: To identify the risk factors associated with primary open-angle glaucoma (POAG) in the Tajimi Study.
Design: Population-based cross-sectional epidemiologic study.
Participants: One hundred nineteen POAG patients and 2755 controls.
Methods: Univariate and multivariate comparison of ocular factors and systemic factors between POAG patients and controls.
Main Outcome Measures: Difference in factors between POAG patients and controls, factors associated with POAG patients, and their odds ratio (OR).
Results: Intraocular pressure (IOP), age, myopia, and history of hypertension differed between POAG patients and controls in univariate analyses. Multivariate analysis with logistic regression with stepwise selection of variables demonstrated that higher IOP (OR, 1.12 [95% confidence interval (CI), 1.04-1.21]), myopia (ORs, 1.85 [95% CI, 1.03-3.31] for low myopia and 2.60 [95% CI, 1.56-4.35] for moderate to high myopia), and older age (OR, 1.06 [95% CI, 1.04-1.08]) were associated with an increased risk of having POAG.
Conclusions: Although the majority (92%) of POAG patients diagnosed in the Tajimi Study had IOP within the normal range, IOP was still identified as a significant risk factor for POAG. Together with IOP, myopia and age were significant risk factors for having POAG.
The Association of Primary Open Angle Glaucoma and Ocular Hypertension with Anti-VEGF Injections.
LoBue S, Albear S, Martin C, Guagliardo A, Chang T Clin Ophthalmol. 2024; 18:3861-3870.
PMID: 39717561 PMC: 11665183. DOI: 10.2147/OPTH.S482123.
Siadat S, Li H, Millette B, Safa B, Wong C, Fard M bioRxiv. 2024; .
PMID: 39554025 PMC: 11565842. DOI: 10.1101/2024.10.23.619950.
Takeda Y, Hanyuda A, Takahashi N, Omodaka K, Ninomiya T, Kiyota N Sci Rep. 2024; 14(1):26329.
PMID: 39487183 PMC: 11530458. DOI: 10.1038/s41598-024-76187-2.
Eccentricity Dependency of Retinal Electrophysiological Deficits in People With Episodic Migraine.
Nguyen B, Park A, McKendrick A Invest Ophthalmol Vis Sci. 2024; 65(11):44.
PMID: 39330986 PMC: 11441450. DOI: 10.1167/iovs.65.11.44.
Akiyama K, Saito H, Aoki S, Shirato S, Iwase A, Sugimoto K Sci Rep. 2024; 14(1):18874.
PMID: 39143152 PMC: 11324904. DOI: 10.1038/s41598-024-69864-9.